Clinical Trials Lead Manager: Mag. Michaela Schachner

The medical study activities of the CCCIT are established in the international top league of clinical cancer research. Thus, we are able to offer adjusted therapies to our patients, depending on their individual disease situation.

Our patients have the earliest possible access to the latest cancer therapies which might only receive final approval and standard therapy status in a few years.

There is an ongoing focus on “Phase 1“ studies. Patients, for whom all existing standard therapies have been exploited, will be offered further, intensely monitored therapy options within “Phase 1“ studies.

The participation to these clinical trials is based solely on a voluntary decision and requires upfront an extensive consent discussion. The patient will be given reasonable time to consider their possible participation in the clinical study and to discuss any open questions with the treating physician.
Only after the required consent form has been signed by the patient and submitted, study-related examinations and subsequently the according therapy will begin.

Our highest priority is our patients, their safety and well-being, values anchored as such also in the Mission Statement of the Universitätsklinik für Innere Medizin III.